See the latest Vistagen Therapeutics Inc stock price (VTGN:XNAS), related news, valuation, dividends and more to help you make your investing decisions. View the latest Vistagen Therapeutics Inc. (VTGN) stock price, news, historical charts, analyst ratings and financial information from WSJ. View the VTGN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the VistaGen Therapeutics. VistaGen Therapeutics (VTGN) has a Smart Score of 5 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Vistagen Therapeutics Inc. research and ratings by Barron's. View VTGN revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.
Vistagen Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. VTGN updated stock price target summary. View the real-time VTGN price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees. The current price of VTGN is USD — it has decreased by −% in the past 24 hours. Watch Vistagen Therapeutics, Inc. stock price performance more closely. Technical Analysis of VTGN The stock indicators reflect a bearish sentiment overall, with the Moving Average Score at 3 indicating strong downward. See the latest Vistagen Therapeutics Inc stock price (VTGN:XNAS), related news, valuation, dividends and more to help you make your investing decisions. VTGN - Vistagen Therapeutics, Inc. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqCM). Vistagen (Nasdaq: VTGN), a late clinical-stage neuroscience-focused biopharmaceutical company dedicated to the development and commercialization of. Vistagen to Report Fiscal Year Financial Results and Host Corporate Update Conference Call on June 11, Vistagen (NASDAQ: VTGN), a late clinical-. Vistagen Therapeutics Inc. (VTGN). VistaGen Therapeutics, Inc NASDAQ: VTGN is a clinical-stage biopharmaceutical company focused developing and commercializing. Complete Vistagen Therapeutics Inc. stock information by Barron's. View real-time VTGN stock price and news, along with industry-best analysis. View the latest Vistagen Therapeutics Inc. (VTGN) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Symbol, %Holdings, 3M %Chg. VTGN, %. Vistagen Therapeutics Inc. VTI, 0%, +%. Total Stock Market ETF Vanguard. IWC, %, %. Vistagen (Nasdaq: VTGN), a late clinical-stage neuroscience-focused biopharmaceutical company dedicated to the development and commercialization of. Vistagen Therapeutics Inc (NASDAQ: VTGN), emphasizing the potential of its lead asset, fasedienol, in clinical development for social anxiety disorder (SAD). According to 3 analysts, the average rating for VTGN stock is "Strong Buy." The month stock price forecast is $, which is an increase of % from the. Vistagen ($VTGN) is a late-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for psychiatric & neurological disorders. Vistagen Therapeutics Inc (VTGN) · 7 Stocks Under $15 Predicted to Boom in the Next 2 Years · 3 Revolutionary Biotech Stocks Poised for 10X Surge · 3 Hidden-Gem. Stock analysis for Vistagen Therapeutics Inc (VTGN:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company. VTGN - Vistagen Therapeutics, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqCM). What are your Vistagen Therapeutics, Inc. (VTGN) stock predictions? 4 Wall Street analysts have issued ratings. Currently, 4 analysts rated VTGN as Bullish, 0.
In depth view into VTGN (Vistagen Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. The current price of VTGN is USD — it has decreased by −% in the past 24 hours. Watch Vistagen Therapeutics, Inc. stock price performance more closely. Choose how much you'd like to invest in VTGN stock. Navigate to the Explore page. Then, type VTGN into the search bar. When you see VTGN stock appear in the. Vistagen Therapeutics, Inc. (ccstreaminggame.online): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Vistagen Therapeutics. VTGN has underperformed the market in the last year with a return of %, while the SPY ETF gained +%. In the last 3 month period, VTGN fell short of the.
VTGN stock analysis and financial data, including key statistics and ratios, valuations, historical price and financial performance of VistaGen. Webull offers VTGN Ent Holdg (VTGN) historical stock prices, in-depth market analysis, NASDAQ: VTGN real-time stock quote data, in-depth charts, free VTGN.